Exhibit 12.1
Gilead Sciences, Inc.
Computation of Ratio of Earnings to Fixed Charges
| Year Ended December 31, | ||||||||||||||||||||
| 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
| Earnings: |
||||||||||||||||||||
| Income before provision for income tax |
$ | 3,913,548 | $ | 3,501,956 | $ | 2,672,698 | $ | 2,211,149 | $ | (677,275 | ) | |||||||||
| Interest expense |
$ | 108,961 | $ | 69,662 | $ | 65,244 | $ | 63,181 | $ | 53,164 | ||||||||||
| Interest portion of operating lease expense |
$ | 16,680 | $ | 14,920 | $ | 11,720 | $ | 11,520 | $ | 9,760 | ||||||||||
| Net loss attributable to non-controlling interest |
$ | 11,508 | $ | 10,163 | $ | 8,564 | $ | 9,108 | $ | 6,266 | ||||||||||
| Total Earnings |
$ | 4,050,697 | $ | 3,596,701 | $ | 2,758,226 | $ | 2,294,958 | $ | (608,085 | ) | |||||||||
| Fixed Charges: |
||||||||||||||||||||
| Interest expense |
$ | 108,961 | $ | 69,662 | $ | 65,244 | $ | 63,181 | $ | 53,164 | ||||||||||
| Capitalized Interest |
$ | 1,473 | $ | 775 | $ | 120 | $ | 366 | $ | 517 | ||||||||||
| Interest portion of operating lease expense |
$ | 16,680 | $ | 14,920 | $ | 11,720 | $ | 11,520 | $ | 9,760 | ||||||||||
| Total Fixed Charges |
$ | 127,114 | $ | 85,357 | $ | 77,084 | $ | 75,067 | $ | 63,441 | ||||||||||
| Ratio of earnings to fixed charges |
31.9 | 42.1 | 35.8 | 30.6 | * | |||||||||||||||
| * | For the year ended December 31, 2006, our earnings were insufficient to cover fixed charges by $671.5 million. |